Literature DB >> 21051099

[Ocular manifestations in patients affected by Morquio syndrome (MPS IV)].

J Couprie1, P Denis, N Guffon, N Reynes, H Masset, F Beby.   

Abstract

PURPOSE: The purpose of this study was to investigate the ocular manifestations in patients suffering from Morquio syndrome.
METHODS: We reviewed the hospital records of 20 patients who underwent ophthalmological follow-up at hôpital Femme-Mère-Enfant, Bron, France, between December 2008 and February 2010.
RESULTS: This retrospective study included 20 patients: 12 males and eight females. The mean age at the beginning of the retrospective study was 23 years. The most common ocular manifestations encountered, in order of frequency, were: corneal opacification (13/20), astigmatism (12/20) and the presence of punctate cataract (6/20). Visual acuity after optical correction was over 7/10 on average. The average best corrected visual acuity was estimated to be over 0.7.
CONCLUSION: Although ocular complications in Morquio syndrome appeared to be associated with relatively well preserved visual acuity, ophthalmological follow-up is recommended to identify potentially curable complications such as astigmatism or lens opacities.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21051099     DOI: 10.1016/j.jfo.2010.09.008

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  13 in total

Review 1.  Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

Authors:  Hira Peracha; Kazuki Sawamoto; Lauren Averill; Heidi Kecskemethy; Mary Theroux; Mihir Thacker; Kyoko Nagao; Christian Pizarro; William Mackenzie; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Toshiyuki Fukao; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-05-15       Impact factor: 4.797

2.  Mucopolysaccharidosis type IVA (Morquio A): a close differential diagnosis of spondylo-epiphyseal dysplasia.

Authors:  Sugata Narayan Biswas; Shinjan Patra; Partha Pratim Chakraborty; Himanshu Barman
Journal:  BMJ Case Rep       Date:  2017-10-20

Review 3.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

Review 4.  Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA.

Authors:  Christian J Hendriksz; Maisoon Al-Jawad; Kenneth I Berger; Sara M Hawley; Rebecca Lawrence; Ciarán Mc Ardle; C Gail Summers; Elizabeth Wright; Elizabeth Braunlin
Journal:  J Inherit Metab Dis       Date:  2012-02-23       Impact factor: 4.982

Review 5.  International guidelines for the management and treatment of Morquio A syndrome.

Authors:  Christian J Hendriksz; Kenneth I Berger; Roberto Giugliani; Paul Harmatz; Christoph Kampmann; William G Mackenzie; Julian Raiman; Martha Solano Villarreal; Ravi Savarirayan
Journal:  Am J Med Genet A       Date:  2014-10-24       Impact factor: 2.802

6.  Comparison of Rebound Tonometry, Perkins Applanation Tonometry and Ocular Response Analyser in Mucopolysaccharidosis Patients.

Authors:  Joanna Wasielica-Poslednik; Christina Butsch; Christina Lampe; Heike Elflein; Julia Lamparter; Veronika Weyer; Susanne Pitz
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

7.  Influence of Corneal Opacity on Intraocular Pressure Assessment in Patients with Lysosomal Storage Diseases.

Authors:  Joanna Wasielica-Poslednik; Giuseppe Politino; Irene Schmidtmann; Katrin Lorenz; Katharina Bell; Norbert Pfeiffer; Susanne Pitz
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

8.  Corneal topometric, aberrometric and biomechanical parameters in mucopolysaccharidosis patients.

Authors:  Joanna Wasielica-Poslednik; Alexander K Schuster; Giuseppe Politino; Susanne Marx-Gross; Katharina Bell; Norbert Pfeiffer; Susanne Pitz
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

9.  Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses.

Authors:  Hsiang-Yu Lin; Wei-Chun Chan; Lee-Jen Chen; Yuan-Chieh Lee; Shu-I Yeh; Dau-Ming Niu; Pao Chin Chiu; Wen-Hui Tsai; Wuh-Liang Hwu; Chih-Kuang Chuang; Shuan-Pei Lin
Journal:  Mol Genet Genomic Med       Date:  2019-03-08       Impact factor: 2.183

10.  Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA.

Authors:  Hsiang-Yu Lin; Chih-Kuang Chuang; Ming-Ren Chen; Pao Chin Chiu; Yu-Yuan Ke; Dau-Ming Niu; Fuu-Jen Tsai; Wuh-Liang Hwu; Ju-Li Lin; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2014-02-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.